Sebastian Guth sharpens his focus at Bayer; As CD47 struggles persist, I-Mab appoints CEO

Sebastian Guth

Bayer is refining Sebastian Guth’s role on June 30, naming him senior Bayer representative and president of Bayer US. Guth had led pharmaceuticals operations in the Americas since December 2018, but he’ll only be in charge of the…
Click here to view original post